Medical Research Council

U.K.’s MRC invests over $17M in stratified medicine research

Thursday, December 13, 2012 08:00 AM

The U.K.’s Medical Research Council (MRC) plans to invest $17.1 million in three major new collaborations that will advance the emerging field of stratified medicine—investigating why different patients with the same diagnosis respond differently to treatments.

More... »


$11.3M awarded to researchers through MRC-AZ compound collaboration

Thursday, November 1, 2012 09:56 AM

The Medical Research Council (MRC) has awarded $11.3 million of funding for 15 research projects awarded through its collaboration with global biopharmaceutical company AstraZeneca, which gave academic researchers unprecedented access to 22 chemical compounds.

More... »


NIHR and MRC fund cystic fibrosis gene therapy trial

Wednesday, March 21, 2012 11:08 AM

A groundbreaking gene therapy trial for cystic fibrosis (CF) will begin in March, thanks to a $4.9 million grant from National Institute for Health Research (NIHR) and the Medical Research Council (MRC) through the Efficacy and Mechanism Evaluation program.

More... »

AstraZeneca, MRC ink collaboration giving UK academia access to 22 compounds

Monday, December 5, 2011 02:14 PM

A wide range of compounds will be made available free of charge to UK medical researchers next year, following an agreement between the Medical Research Council (MRC) and AstraZeneca. Academia will be granted access to 22 compounds, developed by AstraZeneca. Through MRC funding, UK academia will conduct studies to better understand what drives a range of diseases with a view to exploring new treatment opportunities.

More... »

Australian government launches review of health and medical research

Tuesday, July 12, 2011 12:18 PM

The Australian government has issued the draft terms of reference for a strategic review of health and medical research, according to PharmaTimes.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs